Catalyst Wire Dossier Catalyst Wire Dossier

Atrovent Inhaletten

ipratropium bromide · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atrovent Inhaletten, covering 2014-09-12 to 2014-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease

See pricing